Low Level Laser in Isolated Cleft Palate Repair Versus Surgical Correction Without LLL in Healing Process
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03688737 |
|
Recruitment Status : Unknown
Verified September 2018 by El noman Mohamed Kamal El shafie, Cairo University.
Recruitment status was: Not yet recruiting
First Posted : September 28, 2018
Last Update Posted : September 28, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Cleft Palate Children Laser | Other: low level laser Other: placebo | Not Applicable |
Primary objective:
To evaluate the effect of adjunctive use of LLL after surgical correction of cleft palate in improving healing among children with cleft palate Secondary objectives To evaluate the effect of adjunctive use of LLL after surgical correction of cleft palate in decreasing incidence of oronasal fistula after surgical repair among children with cleft palate Study group: Will use LLL after surgical correction of cleft palate at day of surgery, 1st day and 3rd day Control group: Surgical correction of cleft palate without Adjunctive use of LLL
Inclusion criteria:
- Age: between 6 to 18 months of age
- Patient has isolated cleft palate
Exclusion criteria:
- Systemic disease
- Hematological disorder Outcome: Outcome measure (s) (1ry, 2ry) 1ry: healing assessment 2ry: occurrence of oronasal fistula
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 34 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Participants will be randomly assigned to either control or study group in the ratio of 1:1 using random number table. |
| Masking: | Single (Participant) |
| Masking Description: | Single blinded study. Blinding to the patient will be ensured by masking the instruments during the follow up. The patient will be informed of the steps of the follow up (as mentioned in the consent form) without getting into details of the method of follow up. |
| Primary Purpose: | Treatment |
| Official Title: | The Effect of Adjunctive Use of Low Level Laser (LLL) After Surgical Correction of Isolated Cleft Palate Versus Surgical Correction Without LLL in Healing Process |
| Estimated Study Start Date : | October 2018 |
| Estimated Primary Completion Date : | January 2020 |
| Estimated Study Completion Date : | December 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Placebo Comparator: control group
A) Control group: Has Surgical procedures "von Langenbeck technique " to repair cleft palate and will come for follow up visit at day of surgery, 1st day and 3rd day for placebo device like LLL and come for follow up visits at 5th day ,2 weeks, month and 3 months postoperative |
Other: placebo
placebo like device as it like low level laser device shape but with no effect to blind the intervention |
|
Active Comparator: study group
B) Study group: This group will be subjected to the same surgical procedure "von Langenbeck technique "to repair cleft palate but low level laser Therapy will be at day of surgery, 1st day and 3rd day and come for follow up visits at 5th day ,2 weeks, month and 3 months postoperative |
Other: low level laser
LLLT with wavelength (λ) of (600 nm to 700nm), The laser will be held 1 cm away from the surface of the target tissue, the irradiated area is 0,5 cm2.The area of impact is the surgical wound zone and the neighboring 0,5-1,0 cm of the adjacent oral mucosa for 1min and 22sec, at day of surgery, 1st day and 3rd day and come for follow up visits at 5th day ,2 weeks, month and 3 months postoperative
Other Name: wavelength (λ) of (600 nm to 700nm) |
- wound healing [ Time Frame: 2 years ]healing by days to closure
- occurrence of oronasal fistula [ Time Frame: 3 months ]Postoperative complications; mainly oronasal fistula by; clinical observation: inspection, clinical signs: regurgitation of food or drink
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 6 Months to 18 Months (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age: between 6 to 18 months of age
- Patient has isolated cleft palate
Exclusion Criteria:
- Systemic disease
- Hematological disorder
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03688737
| Contact: El noman MK El shafie, M.Sc. | 002001063999203 | nomanmust@yahoo.com | |
| Contact: Basma GM Moussa, Prof | 002001005644098 |
| Responsible Party: | El noman Mohamed Kamal El shafie, Principal Investigator, Cairo University |
| ClinicalTrials.gov Identifier: | NCT03688737 |
| Other Study ID Numbers: |
172162009 |
| First Posted: | September 28, 2018 Key Record Dates |
| Last Update Posted: | September 28, 2018 |
| Last Verified: | September 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
low level laser , cleft palate , healing |
|
Cleft Palate Jaw Abnormalities Jaw Diseases Musculoskeletal Diseases Maxillofacial Abnormalities Craniofacial Abnormalities |
Musculoskeletal Abnormalities Stomatognathic Diseases Mouth Abnormalities Mouth Diseases Stomatognathic System Abnormalities Congenital Abnormalities |

